Chapters:
0:00 Big labs buying up the small
5:00 Providers don’t want to provide proper genetic counseling
9:00 Pharma is a “huge stakeholder”
14;15 Looking beyond the GC bill in Congress
23:10 A reboot of consumer genomics?
Sponsor: Today’s show is made free to all by the upcoming conference, Precision Oncology & Diagnostics 2024, in Chicago on October 15-16th. Book your seat today for this event developed by the editorial team of Precision Oncology News.
Ellen Matloff is back on the show today to discuss the changing landscape of genetic testing and counseling in 2024. She is the founder and CEO of MyGeneCounsil and a strong advocate for the critical role of genetic counselors in healthcare. She also writes a regular column for Forbes magazine.
In 2024, we’ve seen a dramatic transformation of the genetic testing landscape, with big labs buying the small ones. Ellen says this is “forcing genetic testing to go mainstream.”
Surely that’s a good thing. Ellen parses through the good, the bad, and the ugly of the recent changes in the field. We mostly focus on the role of the genetic counselor, for which Ellen has some ideas.
Ellen will be discussing this further with a panel at the upcoming Precision Oncology and Diagnostics 2024 in Chicago.
The Evolving Future of Genetic Counseling with Ellen Matloff, CEO, MyGeneCounsel